- €689.60m
- €2.53bn
- €290.00m
- 33
- 59
- 38
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 309 | 296 | 292 | 302 | 290 |
Cost of Revenue | |||||
Gross Profit | 217 | 205 | 202 | 204 | 196 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 236 | 261 | 74.6 | 214 | 328 |
Operating Profit | 73.1 | 34.1 | 218 | 87.7 | -38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.2 | -45.7 | 157 | 15.1 | -122 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.9 | -27.9 | 121 | 5.1 | -115 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 8.9 | -28 | 121 | 5.4 | -115 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.2 | -44.2 | 96.7 | -25.1 | -144 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.04 | -0.248 | 0.545 | -0.149 | -0.852 |
Dividends per Share |